Physician

Kamal T Patel, M.D.

According to 2025 Medicare claims, Kamal Patel, M.D. (NPI: 1750720025) practices preventive medicine in the Tampa, FL market, with the plurality of this provider's patient population coming from Pasco, FL. This provider's primary affiliated billing organization is NEUSPINE INSTITUTE LLC (NPI: 1861913857; TIN: 821647544) and primary practice location at 33544-1186.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 433 traditional Medicare patients, billed 6,138 HCPCS/CPT codes, and received $310,847 in Medicare payments. The top billing code was 27096 (Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance). Part D data shows 5,325 prescription claims across 751 beneficiaries totaling $226,185 in drug costs, led by Botox (Onabotulinumtoxina). Open Payments data shows 84 records totaling $2,517. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,832 to $310,847. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,208 to $226,185. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$155K$311K2018 Medicare payment: $4,832 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $70,524 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $256,424 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $194,860 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $168,201 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $273,792 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $310,847 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201854106$4,832
20192281,362$70,524
20202266,016$256,424
20211885,225$194,860
20221784,709$168,201
20233762,253$273,792
20244336,138$310,847

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$113K$226K2015 Drug cost: $1,208 (USD; Tot_Drug_Cst)2016 Drug cost: $236 (USD; Tot_Drug_Cst)2019 Drug cost: $2,083 (USD; Tot_Drug_Cst)2020 Drug cost: $24,977 (USD; Tot_Drug_Cst)2021 Drug cost: $49,163 (USD; Tot_Drug_Cst)2022 Drug cost: $81,894 (USD; Tot_Drug_Cst)2023 Drug cost: $138,210 (USD; Tot_Drug_Cst)2024 Drug cost: $226,185 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157097$1,208
20162333$236
2017N/RN/RN/R
2018N/RN/RN/R
201976170$2,083
2020240883$24,977
20212561,381$49,163
20222791,864$81,894
20235163,218$138,210
20247515,325$226,185

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
27096Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance105142$138
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more127127$124
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3511,067$92
Q9966Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml1591,116$0
J1100Injection, dexamethasone sodium phosphate, 1 mg1952,860$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BotoxOnabotulinumtoxina231,806$39,805
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,15931,206$37,748
Xtampza ErOxycodone Myristate531,458$24,672
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen85822,874$16,216
QuliptaAtogepant11330$12,437

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.84$2,517Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kamal T. Patel, M.D.?

Tedicare shows public-source Medicare data for Kamal T. Patel, M.D. (NPI 1750720025), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kamal T. Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kamal T. Patel, M.D.?

Kamal T. Patel, M.D. is linked to NEUSPINE INSTITUTE LLC (billing NPI 1861913857) in the available physician profile data.

Does Kamal T. Patel, M.D. have Open Payments data?

Kamal T. Patel, M.D. has 84 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.